Although osteopontin-c was not identified as a marker when considering all lung cancers together, close to 40% of patients had elevated levels of at least one standard deviation above the healthy mean value, and there was a trend toward higher osteopontin-c levels in higher grade cancers. The gene discussed is SPP1; the disease is cancer.